Trial intelligence / Profile preview

Phase II trial of RO4908463 versus standard of care for hospitalized adults with complicated skin and skin structure infections

2005-002239-29Phase 2Completed

Sponsor
Roche
Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in Complicated skin and skin structure infection (cSSSI) comparing RO4908463 with Standard of care (2 arms). Primary endpoint: Clinical cure rate at EOSE. Started Dec 2005; status: completed.

02

Drugs

tomopenem
03

Conditions

Complicated skin and skin structure infection (cSSSI)

Beyond the preview

Go deeper on 2005-002239-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002239-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call